GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » EV-to-Revenue

Mezzion Pharma Co (XKRX:140410) EV-to-Revenue : 40.77 (As of May. 22, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mezzion Pharma Co's enterprise value is ₩1,063,618 Mil. Mezzion Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩26,090 Mil. Therefore, Mezzion Pharma Co's EV-to-Revenue for today is 40.77.

The historical rank and industry rank for Mezzion Pharma Co's EV-to-Revenue or its related term are showing as below:

XKRX:140410' s EV-to-Revenue Range Over the Past 10 Years
Min: -4.91   Med: 31.42   Max: 167.12
Current: 40.77

During the past 13 years, the highest EV-to-Revenue of Mezzion Pharma Co was 167.12. The lowest was -4.91. And the median was 31.42.

XKRX:140410's EV-to-Revenue is ranked worse than
94.64% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.335 vs XKRX:140410: 40.77

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Mezzion Pharma Co's stock price is ₩37500.00. Mezzion Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩906.58. Therefore, Mezzion Pharma Co's PS Ratio for today is 41.36.


Mezzion Pharma Co EV-to-Revenue Historical Data

The historical data trend for Mezzion Pharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co EV-to-Revenue Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.84 53.06 70.88 10.35 34.58

Mezzion Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.74 32.29 36.45 34.58 43.10

Competitive Comparison of Mezzion Pharma Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's EV-to-Revenue falls into.



Mezzion Pharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mezzion Pharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1063617.812/26090.155
=40.77

Mezzion Pharma Co's current Enterprise Value is ₩1,063,618 Mil.
Mezzion Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩26,090 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mezzion Pharma Co  (XKRX:140410) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mezzion Pharma Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=37500.00/906.581
=41.36

Mezzion Pharma Co's share price for today is ₩37500.00.
Mezzion Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩906.58.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mezzion Pharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co (XKRX:140410) Business Description

Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines